Valuation: Tasly Pharmaceutical Group Co., Ltd

Market Cap 20.92B 3.12B 2.77B 2.59B 2.36B 4.45B 300B 4.49B 31.31B 12.13B 153B 11.71B 11.46B 492B P/E 2026 *
15.7x
P/E 2027 * 13.2x
Enterprise Value 19.37B 2.89B 2.57B 2.4B 2.18B 4.12B 278B 4.16B 28.99B 11.24B 142B 10.85B 10.61B 456B EV / Sales 2026 *
2.24x
EV / Sales 2027 * 1.62x
Free-Float
47.11%
Yield 2026 *
2.78%
Yield 2027 * 3.36%
1 day+1.89%
1 week+2.34%
1 month-4.63%
6 months-2.23%
Current year-7.10%
1 week 13.67
Extreme 13.67
14.1
1 month 13.64
Extreme 13.64
14.87
Current year 12.9
Extreme 12.9
16.24
1 year 12.9
Extreme 12.9
16.24
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 07/05/2024
Director of Finance/CFO 49 08/07/2018
Chief Investment Officer 45 30/04/2025
Director TitleAgeSince
Director/Board Member 72 01/06/2021
Chairman 54 09/08/2026
Director/Board Member 58 07/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+1.89%+2.34%-11.39%-3.58% 3.12B
-0.61%-3.43%+36.07%+117.61% 1,019B
-1.02%-5.60%+35.72%+64.82% 617B
+1.11%-0.58%+12.36%+78.27% 464B
+0.34%-3.01%+61.79%+41.79% 356B
-0.95%-4.05%+20.54%+40.33% 333B
-1.46%-2.89%+10.57%+26.54% 267B
-1.35%-5.43%-6.17%+8.82% 244B
-1.04%-2.79%+35.30%+54.42% 218B
-1.87%-4.10%+28.44%+97.54% 179B
Average -0.50%-2.97%+22.32%+52.65% 370.03B
Weighted average by Cap. -0.60%-3.32%+29.04%+71.09%

Financials

2026 *2027 *
Net sales 8.63B 1.29B 1.14B 1.07B 973M 1.84B 124B 1.85B 12.92B 5.01B 63.28B 4.83B 4.73B 203B 9.36B 1.4B 1.24B 1.16B 1.05B 1.99B 134B 2.01B 14B 5.43B 68.58B 5.24B 5.13B 220B
Net income 1.34B 199M 177M 165M 151M 284M 19.17B 287M 2B 776M 9.8B 749M 733M 31.46B 1.58B 236M 209M 195M 178M 336M 22.66B 339M 2.37B 917M 11.58B 885M 866M 37.18B
Net Debt -1.54B -230M -205M -191M -174M -328M -22.14B -331M -2.31B -895M -11.32B -865M -846M -36.32B -5.71B -852M -757M -706M -644M -1.21B -81.9B -1.23B -8.55B -3.31B -41.87B -3.2B -3.13B -134B
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
30/09/26 CN¥14.00 +1.89% 12,576,273
29/09/26 CN¥13.74 -0.43% 7,945,220
28/09/26 CN¥13.80 +0.88% 10,932,319
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.00CNY
Average target price
17.29CNY
Spread / Average Target
+23.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock